Tag: Biotechnology

Immunome
United States

Immunome Appoints Kinney Horn as Chief Business Officer

BOTHELL, Wash.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the appointment of Kinney Horn as Chief Business Officer. Mr. Horn brings to Immunome extensive experience across life sciences corporate and business development, alliance management, and commercial strategy. “With the recent acquisition of AL102, Immunome is now a clinical stage company, and Kinney’s expertise in … Continue reading Immunome Appoints Kinney Horn as Chief Business Officer

Impact Newswire
Agilent Technologies
United States

Padraig McDonnell Assumes Agilent CEO Role

SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE:A) today announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately. His appointment is part of the company’s CEO transition plan announced Feb. 21. McDonnell is the fourth CEO in Agilent’s history and succeeds Mike McMullen, who will serve as an adviser until he retires Oct. 31. “It’s an incredible honor to serve as CEO … Continue reading Padraig McDonnell Assumes Agilent CEO Role

Impact Newswire
Generate:Biomedicines
United States

Generate: Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer

SOMERVILLE, Mass. – Generate:Biomedicines today announces two key appointments, welcoming Kimberly (Kym) White as the new Chief Corporate Affairs Officer and announcing the promotion of Lisa Wyman to Chief Technical Operations Officer. These appointments not only enhance the company’s leadership team, but also reflect its commitment to gender diversity, with over half of the leadership team represented by women. White’s arrival and Wyman’s promotion are … Continue reading Generate: Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer

Impact Newswire
Scenic Biotech
Europe

Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb

Bristol Myers Squibb gains access to Scenic’s Cell-Seq technology platform to unlock the underlying genetic interactions of cellular pathways for undisclosed targets Scenic to receive an upfront payment and potential additional payments contingent on the achievement of research, development and commercial milestones AMSTERDAM – Scenic Biotech, a pioneer in the field of modifier therapies for severe genetic disorders, today announced that it has entered into … Continue reading Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb

Impact Newswire
CEL-SCI
United States

CEL-SCI Appoints Mario Gobbo to Its Board of Directors

VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM) today announced the appointment of Mario Gobbo to its Board of Directors. “This is an exciting and extremely important moment to join the board of CEL-SCI as it is on the brink of developing a product that will revolutionize certain head and neck cancer therapies and probably other deadly cancers. I am proud and honored to become part of the … Continue reading CEL-SCI Appoints Mario Gobbo to Its Board of Directors

Impact Newswire
Endeavor BioMedicines
United States

Endeavor BioMedicines Announces Appointment of Chris Krueger, J.D., as Chief Operating Officer

SAN DIEGO – Endeavor BioMedicines (“Endeavor”), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, today announced the appointment of Chris Krueger, J.D., as Chief Operating Officer (COO). Mr. Krueger brings extensive experience from the life sciences industry that will be instrumental to Endeavor’s continued growth and success. “Chris is an extremely accomplished life sciences … Continue reading Endeavor BioMedicines Announces Appointment of Chris Krueger, J.D., as Chief Operating Officer

Impact Newswire
KBI Biopharma
United States

KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

DURHAM, N.C.–(BUSINESS WIRE)–KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Jean-Baptiste (JB) Agnus as Chief Business Officer, solidifying KBI’s Executive Team. “JB’s appointment underscores this dedication, perfectly aligning with our team’s mission to deliver innovative, top-tier solutions tailored to our customers’ evolving needs. His servant leadership philosophy will further fortify … Continue reading KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

Impact Newswire
Exact Sciences
United States

Exact Sciences Names Aaron Bloomer as New Chief Financial Officer

MADISON, Wis. – Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today the appointment of Aaron Bloomer as chief financial officer (CFO), effective May 15, 2024. Mr. Bloomer brings to Exact Sciences more than 15 years of finance and accounting experience. He previously held leadership positions at Baxter International and 3M, where he helped improve financial results, drove operational … Continue reading Exact Sciences Names Aaron Bloomer as New Chief Financial Officer

Impact Newswire